<DOC>
	<DOC>NCT02702167</DOC>
	<brief_summary>This trial will compare the efficacy and tolerability of 20 Hz vs. 1 Hz vs. sham repetitive transcranial magnetic stimulation targeting the dorsomedial prefrontal cortex, delivered twice daily over 15 days, in patients with a diagnosis of bulimia or anorexia nervosa. The trial will include structural and functional MRI, EEG, and behavioral measures obtained before, during, and after treatment.</brief_summary>
	<brief_title>High-frequency vs. Low-frequency vs. Sham DMPFC-rTMS for Bulimia and Anorexia Nervosa</brief_title>
	<detailed_description />
	<mesh_term>Anorexia Nervosa</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Bulimia</mesh_term>
	<mesh_term>Bulimia Nervosa</mesh_term>
	<criteria>Inclusion Criteria (Patient): Voluntary and Competent to Consent MINI confirmed Diagnosis of Bulimia Nervosa OR Anorexia Nervosa, Binge/Purge subtype Outpatient Between the ages of 1865 Have had no increase or initiation of any psychotropic medication in the last 4 weeks prior to screening Must adhere to research schedule. Pass the TMS Safety Screening Questionnaire. Failed to achieve a clinical response to at least one pharmacotherapy or behavioral treatment in the current episode. Exclusion Criteria (Patient): Have a concomitant major unstable medical illness, cardiac pacemaker or implanted medical pump Have active suicidal intent Are pregnant Have a lifetime MINI diagnosis of bipolar I or II disorder, schizophrenia, schizoaffective disorder, schizophreniform, delusional disorder, or current psychotic symptoms have a MINI diagnosis of obsessivecompulsive disorder, posttraumatic stress disorder (current or within the last year), anxiety disorder (generalized anxiety disorder, social anxiety disorder, panic disorder), or dysthymia assessed by a study investigator to be primary and causing greater impairment than the ED Have received rTMS for any previous indication due to the potential compromise of subject blinding.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>brain stimulation</keyword>
	<keyword>rTMS</keyword>
</DOC>